Agents61
US equityAerospace / launch / StarlinkNasdaq

SpaceX on the committee board

SpaceX (SPCX) graduated from the private desk after its June 2026 IPO. The public equity case is launch cadence, Starlink cash conversion, Starship optionality, and AI/orbital compute capex — now with EDGAR instead of secondary marks.

What isolated seats argue

Wood-style disruption vs. Buffett-style capital intensity. Value seats ask whether free cash flow can fund Starship and xAI-adjacent compute without permanent dilution; growth seats map Starlink ARPU and launch share.

Filing & structure checks

Musk voting control, lock-up overhang, Starship FAA licensing, defense/commercial mix, and whether post-IPO filings still look like a growth story or a mega-cap utility. Confirm Class A (SPCX) — not a private secondary mark.

SpaceX (SPCX)

Observer · 3 seats

Independent briefs, then clerk assembly · 3 isolated prompts + 1 assembly pass · filing facts from SEC EDGAR (cached 7 days) — not investment advice, no buy button

Ask the desk

Preview seating. Paid desks are 16 / 29 / 48 / 61. $49 is Associate (29), not 61. Partners is the same 61 with more compute.

Isolated briefsAssembly1. Era Trend List2. Cycle Position + Thermometer3. Dual-Track Candidate Pool4. Investment Proposal5. Entry Plan6. Exit Discipline

Filing facts · SEC EDGAR

SPACE EXPLORATION TECHNOLOGIES CORP. · 10-Q Q2 · FY2026 · ended 2026-06-30 · CIK 0001181412

Public filing · not a live quote10-Q Q2 interim (no 10-K yet)P/E · P/B · P/S cached model input
Revenue (YTD)
$12.5B
Revenue YoY (same interim)
+53.7%
Net income
-$4.8B
Diluted EPS
$-1.12
ROE
-3.8%
LT debt / equity
0.30
P/E
n/m
P/B
5.68
P/S
57.80
Cached price
$148.18
Mkt cap (est.)
$723.0B

Filings from SEC companyfacts (us-gaap). P/B, P/S from cached price × diluted shares vs filings. P/S uses YTD sales (interim — not annualized). P/E n/m while diluted EPS ≤ 0. Not a live quote. Not a live quote, not advice, not a buy button. Missing numbers stay blank; P/E shows n/m when diluted EPS ≤ 0.

Isolated briefs
3 seats · no peeking

Each master researches SPCX alone

Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.

Warren Buffettskeptical

Skeptical — the burden of proof is on the bull case. Owner test on SPCX: P/E n/m, P/B 5.68, ROE -3.8%, net income -$4.8B.

Question: “Research SPCX as a US-listed name.”. Owner earnings lens on SPCX. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass. Numbers on file: P/E n/m; P/B 5.68; ROE -3.8%; net income -$4.8B; revenue YoY 53.7%. On file: 10-Q Q2 FY2026 interim; revenue $12.5B YTD; revenue YoY 53.7%; net income -$4.8B; ROE -3.8%; LT debt/equity 0.30; P/E n/m; P/B 5.7; P/S 57.8; price $148.18 cached. A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk. Underwrite frame: Pass for now.

Peter Lynchconstructive

Constructive — the work is worth continuing, not an order. Classify SPCX before cheering growth. revenue YoY 53.7%. P/E n/m.

Question: “Research SPCX as a US-listed name.”. Classify before multiple. Six-category company classification system.. revenue YoY 53.7%. P/E n/m. revenue $12.5B YTD. On file: 10-Q Q2 FY2026 interim; revenue $12.5B YTD; revenue YoY 53.7%; net income -$4.8B; ROE -3.8%; LT debt/equity 0.30; P/E n/m; P/B 5.7; P/S 57.8; price $148.18 cached. Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay. Underwrite frame: Worth further homework.

Charlie Mungercautious

Cautious — the file is open, the bar is not cleared. Invert SPCX first. What has to be false for the bull to die?

Question: “Research SPCX as a US-listed name.”. Invert SPCX. Invert: how would this thesis get killed? List the kill-shots before the romance. On file: 10-Q Q2 FY2026 interim; revenue $12.5B YTD; revenue YoY 53.7%; net income -$4.8B; ROE -3.8%; LT debt/equity 0.30; P/E n/m; P/B 5.7; P/S 57.8; price $148.18 cached. Name what must be true for the bull: earnings quality, leverage (0.30), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job. Underwrite frame: Worth further homework.

Committee tables and charts

Counted from isolated briefs. Ratios are filings or cached model input — not a live quote, not a rating, not a buy button.

Stance mix

3
  • constructive1
  • cautious1
  • skeptical1
  • inconclusive0

Cycle scenario fan (%)

0255075100BoomRecoveryStagflationRecession

Valuation and filings (P/E, P/B, …)

MetricValueNote
P/En/mP/B, P/S from cached price × diluted shares vs filings. P/S uses YTD sales (interim — not annualized). P/E n/m while diluted EPS ≤ 0. Not a live quote.
P/B5.68P/B, P/S from cached price × diluted shares vs filings. P/S uses YTD sales (interim — not annualized). P/E n/m while diluted EPS ≤ 0. Not a live quote.
P/S57.80
ROE-3.8%
LT debt / equity0.30
Revenue (YTD)$12.5B
Revenue YoY (interim)+53.7%
Net income-$4.8B
Diluted EPS$-1.12
Clerk assembly

Then the briefs are stacked — not averaged

constructive
1
cautious
1
skeptical
1
inconclusive
0

Where they agree

  • The clerk stacked isolated notes on: “Research SPCX as a US-listed name.”. Masters did not see each other’s drafts.
  • Quality seats treat “would I own the whole company?” as the filter, not next-quarter beat.
  • This preview triangle is quality, growth classification, and inversion. It is a sample, not the full committee.

Where they split

  • Value/quality seats ask whether it is a business worth owning; growth seats ask whether the story is still underappreciated. Those are different tests.
  • Debate seats write kill-shots before any clerk summary. They are not asked to “meet in the middle.”
  • Constructive and skeptical briefs both survived isolation — the clerk does not erase the split.

Cycle, timing, exit, and quant seats are dark on this plan. A three-seat sample cannot locate the cycle or size a position.

Assembly is a second isolated pass over the briefs. Masters did not read each other. Research simulation — not advice, not a buy button.

Analyst unlocks 16 independent seats (16 isolated prompts + 1 assembly pass).

See Analyst

Split after isolation

Counted from independent briefs only — not a vote, not a recommendation.

33%
34%
33%
1 constructive 1 cautious / inconclusive 1 skeptical
Step 1 · Where does capital flow over the next decade?

Era Trend List

Trend research (Wood, Laffont, and the rest of the era desk) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans
Step 2 · Where are we in the cycle?

Cycle Position Report

Cycle desk (Dalio, Marks, Templeton) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans
Step 3 · What to buy — why this ticker is in the pool, or not

Why this name (dual track)

Value / Quality track

Warren Buffett

SPCX: screened alone against Moat & Management Final Review.

Growth / Opportunity track

Peter Lynch

SPCX: screened alone against Ten-Bagger Hunter.

Step 4 · Bull case vs. red-team interrogation — after isolation

Investment Proposal

Debate starts only after independent briefs exist. Red team still does not see a shared draft.

Charlie MungerDebate chair · inversion: the best way to kill this thesis

Warren BuffettFinal review · 10-year hold test

Full transcript, risk list, and sizing stay on higher seats.

Unlock more seats
Step 5 · When to buy, and how much

Entry Plan

Timing desk (O’Neil and the tape seats) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans
Step 6 · When to sell

Exit Discipline

Exit desk (Livermore, Darvas, Bogle accountability) is locked on Observer.

Unlocks on Committee or Partners (61). Empty seats stay empty — we do not ghost-fill them.

Compare plans

Quant Risk Control

Quant (Thorp Kelly sizing, then the full seven on Committee) is locked on Observer.

Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.

Compare plans

Agents61 is a research simulation and educational tool. Isolated views, splits, and assembly notes only. Not personalized advice. AI-generated.